Press Releases

Sign up to get full access to all our our latest Press Releases. Sign Up
May 24, 2017

Aphria Advances Growth in U.S. Medical Cannabis Market with Completion of Strategic Investment in DFMMJ, and Exclusive Management Agreement with Chestnut Hill Tree Farm LLC

Aphria Inc. and SecureCom Mobile Inc. are pleased to announce the successful first step of their previously announced US expansion strategy.

May 15, 2017

Aphria Triples Production Capacity With Approval From Health Canada for Part II Expansion

Aphria is pleased to announce that the Company has received a license amendment from Health Canada that provides Aphria with additional production space of 57,000 square feet, as part of its Part II expansion at its facility in Leamington, Ontario.

May 11, 2017

Aphria Announces ‘Seed to Sale Certified’ Quality Promise

Aphria today unveiled its 'Seed to Sale Certified' quality promise as part of its long-standing commitment to the cultivation and production of clean and safe medical cannabis.

April 20, 2017

Aphria Raises $100 Million to Fund Continued Expansion of Production Capacity and Other Strategic Opportunities

Aphria announced today that it has secured a $100 million raise, including a $75 million bought deal equity financing and $25 million in debt financing through a five–year term loan.

April 19, 2017

Tetra Bio-Pharma & Aphria Announce Plans for the Joint Distribution of Dried Medical Cannabis in the Maritime Provinces & Quebec

Tetra Bio-Pharma Inc. and Aphria Inc. announced plans today for the joint distribution of dried medical cannabis in the maritime provinces and Quebec.

April 13, 2017

Aphria Welcomes New Federal Recreational Cannabis Legislation

Aphria Inc., a Health Canada Licensed Producer of medical cannabis products, comments on the proposed Cannabis Act announced today..

April 13, 2017

Aphria Records Fifth Consecutive Quarter of Profitability

Aphria Inc. today reported its third quarter results, for the three and nine months ended February 28, 2017.

April 4, 2017

Aphria Launches US Expansion Strategy

Aphria Inc. is pleased to announce the launch of its US expansion strategy through a strategic lead investment in an entity to be renamed Liberty Health Sciences Inc. (“Liberty”)

March 30, 2017

MassRoots Receives US$450,000 in Proceeds From Early Exercise of Warrant by Aphria

Aphria Inc. and MassRoots, Inc. are pleased to announce the early exercise of warrants by Aphria at US$0.90 per share for total proceeds to MassRoots of US$450,000.

March 27, 2017

Aphria Strengthens US Investment Platform, Increases Position in Copperstate Farms Investors to 18.5%

Aphria through its subsidiary Aphria (Arizona) Inc., is pleased to announce that it made an additional investment of $3 million (USD) in Copperstate Farms Investors, LLC (“Investors”).

March 21, 2017

Aphria Continues Success Story with TSX Listing

Aphria today announced that the common shares (the “Common Shares”) of the Company will begin trading on the Toronto Stock Exchange (“TSX”) as of the open of the market on March 22, 2017.

March 8, 2017

Aphria Affirms its Commitment to Producing Safe Medical Cannabis

In light of recent media coverage, Aphria Inc. issued the following statement with respect to its ongoing commitment to providing pharmaceutical-grade cannabis that is free of chemical pesticides.